Rigel Pharmaceuticals, Inc. (RIGL)
48.67
+0.17
(+0.35%)
USD |
NASDAQ |
Sep 04, 16:00
48.65
-0.02
(-0.04%)
After-Hours: 20:00
Rigel Pharmaceuticals SG&A Expense (TTM) : 122.22M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 122.22M |
| March 31, 2026 | 118.84M |
| December 31, 2025 | 115.90M |
| September 30, 2025 | 115.43M |
| June 30, 2025 | 113.54M |
| March 31, 2025 | 112.32M |
| December 31, 2024 | 113.06M |
| September 30, 2024 | 110.39M |
| June 30, 2024 | 108.20M |
| March 31, 2024 | 106.46M |
| December 31, 2023 | 105.74M |
| September 30, 2023 | 111.06M |
| June 30, 2023 | 112.10M |
| March 31, 2023 | 112.78M |
| December 31, 2022 | 112.45M |
| September 30, 2022 | 104.79M |
| June 30, 2022 | 101.77M |
| March 31, 2022 | 97.17M |
| December 31, 2021 | 91.89M |
| September 30, 2021 | 89.19M |
| June 30, 2021 | 83.75M |
| March 31, 2021 | 80.29M |
| December 31, 2020 | 76.60M |
| September 30, 2020 | 73.09M |
| June 30, 2020 | 73.78M |
| Date | Value |
|---|---|
| March 31, 2020 | 73.07M |
| December 31, 2019 | 74.59M |
| September 30, 2019 | 77.65M |
| June 30, 2019 | 77.59M |
| March 31, 2019 | 76.46M |
| December 31, 2018 | 70.00M |
| September 30, 2018 | 63.29M |
| June 30, 2018 | 53.16M |
| March 31, 2018 | 43.91M |
| December 31, 2017 | 37.83M |
| September 30, 2017 | 30.33M |
| June 30, 2017 | 26.94M |
| March 31, 2017 | 23.90M |
| December 31, 2016 | 20.91M |
| September 30, 2016 | 18.48M |
| June 30, 2016 | 18.19M |
| March 31, 2016 | 17.52M |
| December 31, 2015 | 17.81M |
| September 30, 2015 | 19.80M |
| June 30, 2015 | 20.41M |
| March 31, 2015 | 21.70M |
| December 31, 2014 | 22.50M |
| September 30, 2014 | 20.45M |
| June 30, 2014 | 20.23M |
| March 31, 2014 | 19.73M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Cytokinetics, Inc. | 370.47M |
| Perspective Therapeutics, Inc. | 29.46M |
| Capricor Therapeutics, Inc. | 35.43M |
| ACADIA Pharmaceuticals, Inc. | 620.29M |